Unknown

Dataset Information

0

Oxyntomodulin May Distinguish New-Onset Diabetes After Acute Pancreatitis From Type 2 Diabetes.


ABSTRACT: OBJECTIVE:New-onset diabetes is an important sequela of acute pancreatitis, but there are no biomarkers to differentiate it from the much more common type 2 diabetes. The objective was to investigate whether postprandial circulating levels of gut hormones can serve this purpose. METHODS:This was a case-control study nested into a prospective longitudinal cohort study that included 42 insulin-naive cases with new-onset prediabetes/diabetes after acute pancreatitis (NODAP) and prediabetes/diabetes followed by acute pancreatitis (T2D-AP), sex matched with 21 healthy controls. All individuals underwent a standardized mixed-meal test, and blood samples were assayed for gut hormones (glucose-dependent insulinotropic peptide, glucagon-like peptide-1, oxyntomodulin, and peptide YY). Analysis of variance and linear regression analysis were conducted in unadjusted and adjusted models (accounting for age, homeostatic model assessment of ?-cell function, and magnetic resonance imaging-derived body fat composition). RESULTS:Oxyntomodulin levels were significantly lower in NODAP compared with T2D-AP and healthy controls (P = 0.027 and P = 0.001, respectively, in the most adjusted model). Glucagon-like peptide-1 and peptide YY were significantly lower in NODAP compared with T2D-AP (P = 0.001 and P = 0.014, respectively, in the most adjusted model) but not compared with healthy controls (P = 1.000 and P = 0.265, respectively, in the most adjusted model). Glucose-dependent insulinotropic peptide levels were not significantly different between NODAP and T2D-AP. DISCUSSION:Oxyntomodulin is a promising biomarker to guide the differential diagnosis of new-onset diabetes after acute pancreatitis. However, external validation studies are warranted before it can be recommended for routine use in clinical practice.

SUBMITTER: Bharmal SH 

PROVIDER: S-EPMC7145025 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Oxyntomodulin May Distinguish New-Onset Diabetes After Acute Pancreatitis From Type 2 Diabetes.

Bharmal Sakina H SH   Cho Jaelim J   Stuart Charlotte E CE   Alarcon Ramos Gisselle C GC   Ko Juyeon J   Petrov Maxim S MS  

Clinical and translational gastroenterology 20200201 2


<h4>Objective</h4>New-onset diabetes is an important sequela of acute pancreatitis, but there are no biomarkers to differentiate it from the much more common type 2 diabetes. The objective was to investigate whether postprandial circulating levels of gut hormones can serve this purpose.<h4>Methods</h4>This was a case-control study nested into a prospective longitudinal cohort study that included 42 insulin-naive cases with new-onset prediabetes/diabetes after acute pancreatitis (NODAP) and predi  ...[more]

Similar Datasets

| S-EPMC8486922 | biostudies-literature
| S-EPMC6558372 | biostudies-literature
| S-EPMC8741427 | biostudies-literature
2019-02-28 | GSE124284 | GEO
| S-EPMC7441418 | biostudies-literature
| S-EPMC9257058 | biostudies-literature
2019-02-28 | GSE124400 | GEO
| S-EPMC8668202 | biostudies-literature
| S-EPMC6478438 | biostudies-literature
| S-EPMC4002758 | biostudies-literature